Paparella Raffaele, Marturano Monia, Pelino Laura, Scarpa Alessandra, Scambia Giovanni, La Torre Giuseppe, Paparella Pierluigi
Association Columbus-Operative Unit, Urogynecology and Reconstructive Surgery of Pelvic Floor, Department for the Protection of the Health of Women and Rising Life, Catholic University of Sacred Heart, Via Giuseppe Moscati 31, 00168 Rome, Italy.
Int Urogynecol J. 2010 Nov;21(11):1327-36. doi: 10.1007/s00192-010-1197-y. Epub 2010 Jun 29.
The aim of this study was to prospectively and randomly compare the outcome of surgical treatment of female stress urinary incontinence (SUI) using the same outside-inside transobturator technique with biological (PelviLaceTO) or synthetic (UretexTO) material sling, evaluating if the biological material can prevent vaginal erosion retaining the "cure rate" of this surgical technique.
Seventy patients with SUI were selected, randomly assigned to either UretexTO (n = 34) or PelviLaceTO (n = 36), and underwent the same surgery.
There is no significant difference between two study arms with regard to objective and subjective cure rates and quality of life. In both groups we had an overlap cure rate (UretexTO group 88.2% vs PelviLaceTO group 88.8%) at mean 3 years follow-up. It found no perioperative complications nor vaginal erosions.
UretexTO and PelviLaceTO are two similarly safe and efficient slings in the management of SUI, with a good patient satisfaction and without any complications.
本研究的目的是前瞻性、随机地比较采用相同的经闭孔从外向内技术,使用生物材料(PelviLaceTO)或合成材料(UretexTO)吊带治疗女性压力性尿失禁(SUI)的手术效果,评估生物材料在保持该手术技术“治愈率”的同时能否预防阴道侵蚀。
选取70例SUI患者,随机分为UretexTO组(n = 34)或PelviLaceTO组(n = 36),并接受相同的手术。
在客观和主观治愈率及生活质量方面,两个研究组之间无显著差异。在平均3年的随访中,两组的治愈率有重叠(UretexTO组为88.2%,PelviLaceTO组为88.8%)。未发现围手术期并发症及阴道侵蚀。
在SUI的治疗中,UretexTO和PelviLaceTO是两种同样安全有效的吊带,患者满意度高且无任何并发症。